The global market for Transplantation of Hematopoietic Stem Cells was estimated to be worth US$ 1348 million in 2023 and is forecast to a readjusted size of US$ 2627.2 million by 2030 with a CAGR of 10.0% during the forecast period 2024-2030

Transplantation of Hematopoietic Stem Cells - Market

Over 51 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.

The Transplantation of Hematopoietic Stem Cells market is primarily driven by its potential to provide curative treatments for various hematological disorders, including leukemia, lymphoma, and certain genetic diseases. Hematopoietic stem cell transplantation (HSCT) involves replacing damaged or malfunctioning bone marrow with healthy stem cells to restore normal blood cell production. The increasing prevalence of hematological diseases, coupled with advancements in transplantation techniques, contributes to market growth. Moreover, the demonstrated benefits of HSCT in achieving long-term remission, improving overall survival rates, and offering a potential cure for patients with limited treatment options further propel adoption. However, challenges include finding suitable donors, addressing potential graft-versus-host disease and other complications, and managing post-transplant care. Navigating patient-donor matching, ensuring graft compatibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in transplantation science, collaborations between medical institutions and stem cell banks, and comprehensive education on the benefits and potential challenges of hematopoietic stem cell transplantation while addressing the evolving challenges associated with donor availability and patient outcomes.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transplantation of Hematopoietic Stem Cells, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Transplantation of Hematopoietic Stem Cells by region & country, by Type, and by Application.

The Transplantation of Hematopoietic Stem Cells market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transplantation of Hematopoietic Stem Cells.

Market Segmentation

Scope of Transplantation of Hematopoietic Stem Cells - Market Report

Report Metric	Details
Report Name	Transplantation of Hematopoietic Stem Cells - Market
Forecasted market size in 2030	US$ 2627.2 million
CAGR	10.0%
Forecasted years	2024 - 2030
Segment by Type:	Stem Cells Storage Stem Cells Consumables
Segment by Application	Leukemia Lymphoproliferative Disorders Solid Tumors Non-Malignant Disorders
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies, Vcanbio, Merck Millipore, Lonza Group, CellGenix Technologie Transfer, ThermoGenesis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Transplantation of Hematopoietic Stem Cells manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Transplantation of Hematopoietic Stem Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Transplantation of Hematopoietic Stem Cells in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Transplantation of Hematopoietic Stem Cells - Market size in 2030?

Ans: The Transplantation of Hematopoietic Stem Cells - Market size in 2030 will be US$ 2627.2 million.

Who are the main players in the Transplantation of Hematopoietic Stem Cells - Market report?

Ans: The main players in the Transplantation of Hematopoietic Stem Cells - Market are CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies, Vcanbio, Merck Millipore, Lonza Group, CellGenix Technologie Transfer, ThermoGenesis

What are the Application segmentation covered in the Transplantation of Hematopoietic Stem Cells - Market report?

Ans: The Applications covered in the Transplantation of Hematopoietic Stem Cells - Market report are Leukemia, Lymphoproliferative Disorders, Solid Tumors, Non-Malignant Disorders

What are the Type segmentation covered in the Transplantation of Hematopoietic Stem Cells - Market report?

Ans: The Types covered in the Transplantation of Hematopoietic Stem Cells - Market report are Stem Cells Storage, Stem Cells Consumables

1 Market Overview

1.1 Transplantation of Hematopoietic Stem Cells Product Introduction

1.2 Global Transplantation of Hematopoietic Stem Cells Market Size Forecast

1.3 Transplantation of Hematopoietic Stem Cells Market Trends & Drivers

1.3.1 Transplantation of Hematopoietic Stem Cells Industry Trends

1.3.2 Transplantation of Hematopoietic Stem Cells Market Drivers & Opportunity

1.3.3 Transplantation of Hematopoietic Stem Cells Market Challenges

1.3.4 Transplantation of Hematopoietic Stem Cells Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Transplantation of Hematopoietic Stem Cells Players Revenue Ranking (2023)

2.2 Global Transplantation of Hematopoietic Stem Cells Revenue by Company (2019-2024)

2.3 Key Companies Transplantation of Hematopoietic Stem Cells Manufacturing Base Distribution and Headquarters

2.4 Key Companies Transplantation of Hematopoietic Stem Cells Product Offered

2.5 Key Companies Time to Begin Mass Production of Transplantation of Hematopoietic Stem Cells

2.6 Transplantation of Hematopoietic Stem Cells Market Competitive Analysis

2.6.1 Transplantation of Hematopoietic Stem Cells Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Transplantation of Hematopoietic Stem Cells Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transplantation of Hematopoietic Stem Cells as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Stem Cells Storage

3.1.2 Stem Cells Consumables

3.2 Global Transplantation of Hematopoietic Stem Cells Sales Value by Type

3.2.1 Global Transplantation of Hematopoietic Stem Cells Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Transplantation of Hematopoietic Stem Cells Sales Value, by Type (2019-2030)

3.2.3 Global Transplantation of Hematopoietic Stem Cells Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Leukemia

4.1.2 Lymphoproliferative Disorders

4.1.3 Solid Tumors

4.1.4 Non-Malignant Disorders

4.2 Global Transplantation of Hematopoietic Stem Cells Sales Value by Application

4.2.1 Global Transplantation of Hematopoietic Stem Cells Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Transplantation of Hematopoietic Stem Cells Sales Value, by Application (2019-2030)

4.2.3 Global Transplantation of Hematopoietic Stem Cells Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Transplantation of Hematopoietic Stem Cells Sales Value by Region

5.1.1 Global Transplantation of Hematopoietic Stem Cells Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Transplantation of Hematopoietic Stem Cells Sales Value by Region (2019-2024)

5.1.3 Global Transplantation of Hematopoietic Stem Cells Sales Value by Region (2025-2030)

5.1.4 Global Transplantation of Hematopoietic Stem Cells Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

5.2.2 North America Transplantation of Hematopoietic Stem Cells Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

5.3.2 Europe Transplantation of Hematopoietic Stem Cells Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

5.4.2 Asia Pacific Transplantation of Hematopoietic Stem Cells Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

5.5.2 South America Transplantation of Hematopoietic Stem Cells Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

5.6.2 Middle East & Africa Transplantation of Hematopoietic Stem Cells Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Transplantation of Hematopoietic Stem Cells Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Transplantation of Hematopoietic Stem Cells Sales Value

6.3 United States

6.3.1 United States Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

6.3.2 United States Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Transplantation of Hematopoietic Stem Cells Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

6.4.2 Europe Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Transplantation of Hematopoietic Stem Cells Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

6.5.2 China Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

6.5.3 China Transplantation of Hematopoietic Stem Cells Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

6.6.2 Japan Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Transplantation of Hematopoietic Stem Cells Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

6.7.2 South Korea Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Transplantation of Hematopoietic Stem Cells Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

6.8.2 Southeast Asia Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Transplantation of Hematopoietic Stem Cells Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Transplantation of Hematopoietic Stem Cells Sales Value, 2019-2030

6.9.2 India Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

6.9.3 India Transplantation of Hematopoietic Stem Cells Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 CBR Systems

7.1.1 CBR Systems Profile

7.1.2 CBR Systems Main Business

7.1.3 CBR Systems Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

7.1.4 CBR Systems Transplantation of Hematopoietic Stem Cells Revenue (US$ Million) & (2019-2024)

7.1.5 CBR Systems Recent Developments

7.2 China Cord Blood Corporation

7.2.1 China Cord Blood Corporation Profile

7.2.2 China Cord Blood Corporation Main Business

7.2.3 China Cord Blood Corporation Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

7.2.4 China Cord Blood Corporation Transplantation of Hematopoietic Stem Cells Revenue (US$ Million) & (2019-2024)

7.2.5 China Cord Blood Corporation Recent Developments

7.3 ViaCord

7.3.1 ViaCord Profile

7.3.2 ViaCord Main Business

7.3.3 ViaCord Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

7.3.4 ViaCord Transplantation of Hematopoietic Stem Cells Revenue (US$ Million) & (2019-2024)

7.3.5 Thermo Fisher Scientific Recent Developments

7.4 Thermo Fisher Scientific

7.4.1 Thermo Fisher Scientific Profile

7.4.2 Thermo Fisher Scientific Main Business

7.4.3 Thermo Fisher Scientific Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

7.4.4 Thermo Fisher Scientific Transplantation of Hematopoietic Stem Cells Revenue (US$ Million) & (2019-2024)

7.4.5 Thermo Fisher Scientific Recent Developments

7.5 STEMCELL Technologies

7.5.1 STEMCELL Technologies Profile

7.5.2 STEMCELL Technologies Main Business

7.5.3 STEMCELL Technologies Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

7.5.4 STEMCELL Technologies Transplantation of Hematopoietic Stem Cells Revenue (US$ Million) & (2019-2024)

7.5.5 STEMCELL Technologies Recent Developments

7.6 Vcanbio

7.6.1 Vcanbio Profile

7.6.2 Vcanbio Main Business

7.6.3 Vcanbio Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

7.6.4 Vcanbio Transplantation of Hematopoietic Stem Cells Revenue (US$ Million) & (2019-2024)

7.6.5 Vcanbio Recent Developments

7.7 Merck Millipore

7.7.1 Merck Millipore Profile

7.7.2 Merck Millipore Main Business

7.7.3 Merck Millipore Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

7.7.4 Merck Millipore Transplantation of Hematopoietic Stem Cells Revenue (US$ Million) & (2019-2024)

7.7.5 Merck Millipore Recent Developments

7.8 Lonza Group

7.8.1 Lonza Group Profile

7.8.2 Lonza Group Main Business

7.8.3 Lonza Group Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

7.8.4 Lonza Group Transplantation of Hematopoietic Stem Cells Revenue (US$ Million) & (2019-2024)

7.8.5 Lonza Group Recent Developments

7.9 CellGenix Technologie Transfer

7.9.1 CellGenix Technologie Transfer Profile

7.9.2 CellGenix Technologie Transfer Main Business

7.9.3 CellGenix Technologie Transfer Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

7.9.4 CellGenix Technologie Transfer Transplantation of Hematopoietic Stem Cells Revenue (US$ Million) & (2019-2024)

7.9.5 CellGenix Technologie Transfer Recent Developments

7.10 ThermoGenesis

7.10.1 ThermoGenesis Profile

7.10.2 ThermoGenesis Main Business

7.10.3 ThermoGenesis Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

7.10.4 ThermoGenesis Transplantation of Hematopoietic Stem Cells Revenue (US$ Million) & (2019-2024)

7.10.5 ThermoGenesis Recent Developments

8 Industry Chain Analysis

8.1 Transplantation of Hematopoietic Stem Cells Industrial Chain

8.2 Transplantation of Hematopoietic Stem Cells Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Transplantation of Hematopoietic Stem Cells Sales Model

8.5.2 Sales Channel

8.5.3 Transplantation of Hematopoietic Stem Cells Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

CBR Systems

China Cord Blood Corporation

ViaCord

Thermo Fisher Scientific

StemCell Technologies

Vcanbio

Merck Millipore

Lonza Group

CellGenix Technologie Transfer

Thermogenesis

List of Tables

Table 1. Transplantation of Hematopoietic Stem Cells Market Trends

Table 2. Transplantation of Hematopoietic Stem Cells Market Drivers & Opportunity

Table 3. Transplantation of Hematopoietic Stem Cells Market Challenges

Table 4. Transplantation of Hematopoietic Stem Cells Market Restraints

Table 5. Global Transplantation of Hematopoietic Stem Cells Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Transplantation of Hematopoietic Stem Cells Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Transplantation of Hematopoietic Stem Cells Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Transplantation of Hematopoietic Stem Cells Product Type

Table 9. Key Companies Time to Begin Mass Production of Transplantation of Hematopoietic Stem Cells

Table 10. Global Transplantation of Hematopoietic Stem Cells Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transplantation of Hematopoietic Stem Cells as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Transplantation of Hematopoietic Stem Cells Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Transplantation of Hematopoietic Stem Cells Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Transplantation of Hematopoietic Stem Cells Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Transplantation of Hematopoietic Stem Cells Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Transplantation of Hematopoietic Stem Cells Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Transplantation of Hematopoietic Stem Cells Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Transplantation of Hematopoietic Stem Cells Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Transplantation of Hematopoietic Stem Cells Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Transplantation of Hematopoietic Stem Cells Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Transplantation of Hematopoietic Stem Cells Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Transplantation of Hematopoietic Stem Cells Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Transplantation of Hematopoietic Stem Cells Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Transplantation of Hematopoietic Stem Cells Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Transplantation of Hematopoietic Stem Cells Sales Value by Region (2019-2024) & (%)

Table 27. Global Transplantation of Hematopoietic Stem Cells Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Transplantation of Hematopoietic Stem Cells Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Transplantation of Hematopoietic Stem Cells Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Transplantation of Hematopoietic Stem Cells Sales Value, (2025-2030) & (US$ Million)

Table 31. CBR Systems Basic Information List

Table 32. CBR Systems Description and Business Overview

Table 33. CBR Systems Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

Table 34. Revenue (US$ Million) in Transplantation of Hematopoietic Stem Cells Business of CBR Systems (2019-2024)

Table 35. CBR Systems Recent Developments

Table 36. China Cord Blood Corporation Basic Information List

Table 37. China Cord Blood Corporation Description and Business Overview

Table 38. China Cord Blood Corporation Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

Table 39. Revenue (US$ Million) in Transplantation of Hematopoietic Stem Cells Business of China Cord Blood Corporation (2019-2024)

Table 40. China Cord Blood Corporation Recent Developments

Table 41. ViaCord Basic Information List

Table 42. ViaCord Description and Business Overview

Table 43. ViaCord Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

Table 44. Revenue (US$ Million) in Transplantation of Hematopoietic Stem Cells Business of ViaCord (2019-2024)

Table 45. ViaCord Recent Developments

Table 46. Thermo Fisher Scientific Basic Information List

Table 47. Thermo Fisher Scientific Description and Business Overview

Table 48. Thermo Fisher Scientific Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

Table 49. Revenue (US$ Million) in Transplantation of Hematopoietic Stem Cells Business of Thermo Fisher Scientific (2019-2024)

Table 50. Thermo Fisher Scientific Recent Developments

Table 51. STEMCELL Technologies Basic Information List

Table 52. STEMCELL Technologies Description and Business Overview

Table 53. STEMCELL Technologies Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

Table 54. Revenue (US$ Million) in Transplantation of Hematopoietic Stem Cells Business of STEMCELL Technologies (2019-2024)

Table 55. STEMCELL Technologies Recent Developments

Table 56. Vcanbio Basic Information List

Table 57. Vcanbio Description and Business Overview

Table 58. Vcanbio Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

Table 59. Revenue (US$ Million) in Transplantation of Hematopoietic Stem Cells Business of Vcanbio (2019-2024)

Table 60. Vcanbio Recent Developments

Table 61. Merck Millipore Basic Information List

Table 62. Merck Millipore Description and Business Overview

Table 63. Merck Millipore Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

Table 64. Revenue (US$ Million) in Transplantation of Hematopoietic Stem Cells Business of Merck Millipore (2019-2024)

Table 65. Merck Millipore Recent Developments

Table 66. Lonza Group Basic Information List

Table 67. Lonza Group Description and Business Overview

Table 68. Lonza Group Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

Table 69. Revenue (US$ Million) in Transplantation of Hematopoietic Stem Cells Business of Lonza Group (2019-2024)

Table 70. Lonza Group Recent Developments

Table 71. CellGenix Technologie Transfer Basic Information List

Table 72. CellGenix Technologie Transfer Description and Business Overview

Table 73. CellGenix Technologie Transfer Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

Table 74. Revenue (US$ Million) in Transplantation of Hematopoietic Stem Cells Business of CellGenix Technologie Transfer (2019-2024)

Table 75. CellGenix Technologie Transfer Recent Developments

Table 76. ThermoGenesis Basic Information List

Table 77. ThermoGenesis Description and Business Overview

Table 78. ThermoGenesis Transplantation of Hematopoietic Stem Cells Products, Services and Solutions

Table 79. Revenue (US$ Million) in Transplantation of Hematopoietic Stem Cells Business of ThermoGenesis (2019-2024)

Table 80. ThermoGenesis Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Transplantation of Hematopoietic Stem Cells Downstream Customers

Table 84. Transplantation of Hematopoietic Stem Cells Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Transplantation of Hematopoietic Stem Cells Product Picture

Figure 2. Global Transplantation of Hematopoietic Stem Cells Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Transplantation of Hematopoietic Stem Cells Sales Value (2019-2030) & (US$ Million)

Figure 4. Transplantation of Hematopoietic Stem Cells Report Years Considered

Figure 5. Global Transplantation of Hematopoietic Stem Cells Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Transplantation of Hematopoietic Stem Cells Revenue in 2023

Figure 7. Transplantation of Hematopoietic Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Stem Cells Storage Picture

Figure 9. Stem Cells Consumables Picture

Figure 10. Global Transplantation of Hematopoietic Stem Cells Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Transplantation of Hematopoietic Stem Cells Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Leukemia

Figure 13. Product Picture of Lymphoproliferative Disorders

Figure 14. Product Picture of Solid Tumors

Figure 15. Product Picture of Non-Malignant Disorders

Figure 16. Global Transplantation of Hematopoietic Stem Cells Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Transplantation of Hematopoietic Stem Cells Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Transplantation of Hematopoietic Stem Cells Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Transplantation of Hematopoietic Stem Cells Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Transplantation of Hematopoietic Stem Cells Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Transplantation of Hematopoietic Stem Cells Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Transplantation of Hematopoietic Stem Cells Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Transplantation of Hematopoietic Stem Cells Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Transplantation of Hematopoietic Stem Cells Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Transplantation of Hematopoietic Stem Cells Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Transplantation of Hematopoietic Stem Cells Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Transplantation of Hematopoietic Stem Cells Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Transplantation of Hematopoietic Stem Cells Sales Value (%), (2019-2030)

Figure 29. United States Transplantation of Hematopoietic Stem Cells Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Transplantation of Hematopoietic Stem Cells Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Transplantation of Hematopoietic Stem Cells Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Transplantation of Hematopoietic Stem Cells Sales Value by Application (%), 2023 VS 2030

Figure 35. China Transplantation of Hematopoietic Stem Cells Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

Figure 37. China Transplantation of Hematopoietic Stem Cells Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Transplantation of Hematopoietic Stem Cells Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Transplantation of Hematopoietic Stem Cells Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Transplantation of Hematopoietic Stem Cells Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Transplantation of Hematopoietic Stem Cells Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Transplantation of Hematopoietic Stem Cells Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Transplantation of Hematopoietic Stem Cells Sales Value by Application (%), 2023 VS 2030

Figure 47. India Transplantation of Hematopoietic Stem Cells Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Transplantation of Hematopoietic Stem Cells Sales Value by Type (%), 2023 VS 2030

Figure 49. India Transplantation of Hematopoietic Stem Cells Sales Value by Application (%), 2023 VS 2030

Figure 50. Transplantation of Hematopoietic Stem Cells Industrial Chain

Figure 51. Transplantation of Hematopoietic Stem Cells Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Parkinson's Disease Therapeutics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10O13828

Thu Jan 02 00:00:00 UTC 2025

Add to Cart

Global Osteoarthritis Drugs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-35A3548

Tue Dec 31 00:00:00 UTC 2024

Add to Cart

Global Edema Clinical Trials Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-6J3045

Tue Dec 31 00:00:00 UTC 2024

Add to Cart

Global Amyotrophic Lateral Sclerosis Therapeutics Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-34U13892

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions